Cowen Financial Products Reports 898,630 Share Stake in Exagen Inc.

TL;DR

**Cowen Financial Products holds 898,630 shares of Exagen, signaling a notable institutional stake.**

AI Summary

Cowen Financial Products LLC, a New York-based financial firm, has updated its ownership stake in Exagen Inc. (NASDAQ: XGN), a medical laboratories company, as of December 29, 2023. The filing, an SC 13G/A, reveals that Cowen now beneficially owns 898,630 shares of Exagen's Common Stock, representing a significant holding. This matters to investors because it indicates a major institutional investor's current position, which can influence market perception and potentially signal confidence or concern in Exagen's future performance.

Why It Matters

This filing shows a large institutional investor's current position in Exagen, providing insight into their conviction and potentially influencing other investors' decisions.

Risk Assessment

Risk Level: low — This is an amendment to a passive ownership filing, indicating a change in a significant holder's stake rather than an aggressive activist move.

Analyst Insight

Investors should note Cowen Financial Products LLC's continued significant, albeit passive, stake in Exagen Inc. and consider it as part of their broader due diligence on institutional ownership trends for the stock.

Key Numbers

• 898,630 — Shares Beneficially Owned (Represents Cowen Financial Products LLC's total holding in Exagen Inc.)

Key Players & Entities

• Cowen Financial Products LLC (company) — the reporting person and beneficial owner
• Exagen Inc. (company) — the issuer of the securities
• 898,630 (dollar_amount) — shares beneficially owned by Cowen Financial Products LLC
• December 29, 2023 (date) — date of the event requiring the filing

Forward-Looking Statements

• Cowen Financial Products LLC will maintain a significant, passive stake in Exagen Inc. for the foreseeable future. (Cowen Financial Products LLC) — medium confidence, target: Q3 2024

FAQ

Filing Documents

• xgna4_20224.htm (SC 13G/A) — 25KB
• 0001085146-24-000643.txt ( ) — 27KB

(a)

ITEM 1(a). NAME OF ISSUER: Exagen Inc.

(b)

ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 1261 Liberty Way Vista, CA 92081

(a)

ITEM 2(a). NAME OF PERSON FILING: Cowen Financial Products LLC

(b)

ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: 599 Lexington Ave New York, NY 10022

(c)

ITEM 2(c). CITIZENSHIP: USA

(d)

ITEM 2(d). TITLE OF CLASS OF SECURITIES: Common Stock

(e)

ITEM 2(e). CUSIP NUMBER: 30068x103 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTION 240.13d-1(b), or 13d-2(b) or (c) CHECK WHETHER THE PERSON FILING IS A: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78c); (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) [ ] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) [ ] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) [ ] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d1(b)(1)(ii)(J), please specify the type of institution: ITEM 4. (a) Amount beneficially owned: 898,630 (b) Percent of class: 5.27% (c) Number of shares as to which the person has: (i) sole power to vote or to direct the vote: Cowen Financial Products LLC : 898,630 (ii) shared power to vote or to direct the vote: Cowen Financial Products LLC : (iii) sole power to dispose or direct the disposition of: Cowen Financial Products LLC : 898,630 (iv) shared power to dispose or to direct the disposition of: Cowen Financial Products LLC : ITEM 5. If this statement is being filed to report the fact that as of the date her

View Full Filing

View this SC 13G/A filing on SEC EDGAR